IOL CHEMICALS & PHARM. | INDOCO REMEDIES | IOL CHEMICALS & PHARM./ INDOCO REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 30.5 | 43.3% | View Chart |
P/BV | x | 1.5 | 3.0 | 50.2% | View Chart |
Dividend Yield | % | 1.0 | 0.7 | 153.7% |
IOL CHEMICALS & PHARM. INDOCO REMEDIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
INDOCO REMEDIES Mar-23 |
IOL CHEMICALS & PHARM./ INDOCO REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 423 | 126.8% | |
Low | Rs | 272 | 308 | 88.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 181.1 | 208.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 15.4 | 153.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 23.1 | 136.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.25 | 177.8% | |
Avg Dividend yield | % | 1.0 | 0.6 | 160.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 111.5 | 230.3% | |
Shares outstanding (eoy) | m | 58.71 | 92.15 | 63.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.0 | 53.1% | |
Avg P/E ratio | x | 17.1 | 23.7 | 72.1% | |
P/CF ratio (eoy) | x | 12.8 | 15.8 | 81.0% | |
Price / Book Value ratio | x | 1.6 | 3.3 | 48.0% | |
Dividend payout | % | 16.9 | 14.6 | 115.8% | |
Avg Mkt Cap | Rs m | 23,743 | 33,683 | 70.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 3,226 | 52.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 16,686 | 132.9% | |
Other income | Rs m | 256 | 24 | 1,074.2% | |
Total revenues | Rs m | 22,427 | 16,710 | 134.2% | |
Gross profit | Rs m | 2,257 | 2,860 | 78.9% | |
Depreciation | Rs m | 462 | 706 | 65.4% | |
Interest | Rs m | 165 | 250 | 65.8% | |
Profit before tax | Rs m | 1,887 | 1,928 | 97.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 505 | 98.0% | |
Profit after tax | Rs m | 1,391 | 1,423 | 97.8% | |
Gross profit margin | % | 10.2 | 17.1 | 59.4% | |
Effective tax rate | % | 26.2 | 26.2 | 100.1% | |
Net profit margin | % | 6.3 | 8.5 | 73.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 8,082 | 119.6% | |
Current liabilities | Rs m | 5,025 | 4,245 | 118.4% | |
Net working cap to sales | % | 20.9 | 23.0 | 91.0% | |
Current ratio | x | 1.9 | 1.9 | 101.0% | |
Inventory Days | Days | 43 | 25 | 172.5% | |
Debtors Days | Days | 8 | 768 | 1.1% | |
Net fixed assets | Rs m | 11,017 | 9,055 | 121.7% | |
Share capital | Rs m | 587 | 184 | 318.6% | |
"Free" reserves | Rs m | 14,490 | 10,092 | 143.6% | |
Net worth | Rs m | 15,077 | 10,276 | 146.7% | |
Long term debt | Rs m | 0 | 1,435 | 0.0% | |
Total assets | Rs m | 20,684 | 17,137 | 120.7% | |
Interest coverage | x | 12.5 | 8.7 | 143.1% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.0 | 110.1% | |
Return on assets | % | 7.5 | 9.8 | 77.1% | |
Return on equity | % | 9.2 | 13.8 | 66.7% | |
Return on capital | % | 13.6 | 18.6 | 73.1% | |
Exports to sales | % | 26.7 | 47.5 | 56.4% | |
Imports to sales | % | 0 | 11.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 7,919 | 74.9% | |
Imports (cif) | Rs m | NA | 1,917 | 0.0% | |
Fx inflow | Rs m | 5,930 | 7,919 | 74.9% | |
Fx outflow | Rs m | 6,052 | 1,917 | 315.6% | |
Net fx | Rs m | -122 | 6,002 | -2.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,788 | 68.4% | |
From Investments | Rs m | -1,200 | -2,082 | 57.6% | |
From Financial Activity | Rs m | -41 | 228 | -18.0% | |
Net Cashflow | Rs m | -18 | -65 | 28.2% |
Indian Promoters | % | 48.2 | 58.7 | 82.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 21.3 | 8.0% | |
FIIs | % | 1.4 | 1.9 | 72.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 41.3 | 125.5% | |
Shareholders | 130,003 | 33,201 | 391.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Indoco Remedies | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.87% | 0.32% | -0.50% |
1-Month | -4.21% | 0.42% | 2.09% |
1-Year | -3.79% | 5.71% | 49.73% |
3-Year CAGR | -11.92% | 1.45% | 14.19% |
5-Year CAGR | 15.43% | 10.95% | 19.18% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Indoco Remedies share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Indoco Remedies the stake stands at 58.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Indoco Remedies.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Indoco Remedies paid Rs 2.3, and its dividend payout ratio stood at 14.6%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Indoco Remedies.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.